万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>化学>>有机化学

HETEROCYCLIC COMMUNICATIONS《杂环通讯》 (官网投稿)

简介
  • 期刊简称HETEROCYCL COMMUN
  • 参考译名《杂环通讯》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率9.30%
  • 主要研究方向化学-CHEMISTRY, ORGANIC 有机化学

主要研究方向:

等待设置主要研究方向
化学-CHEMISTRY, ORGANIC 有机化学

HETEROCYCLIC COMMUNICATIONS《杂环通讯》(双月刊). Heterocyclic Communications (HC) is an open-access, peer-reviewed journal publishing preliminary communications, re...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://www.degruyter.com/journal/key/HC/html

3、投稿网址:https://www.editorialmanager.com/hcc/

4、官网邮箱:mhenary1@gsu.edu(主编)

irmina.fortunato@degruyter.com(编辑部)

更多编辑邮箱如下。

5、期刊刊期:双月刊,一年出版六期。

2021412日星期一

                              

 

投稿须知【官网信息】

 

Submit

Manuscripts should be submitted to the journal via online submission system Editorial Manager available for this journal at https://www.editorialmanager.com/hcc In case of problems, please contact the Editorial Office of this journal at irmina.fortunato@degruyter.com.

EDITORIAL POLICY

Unpublished material: Submission of a manuscript implies that the work described is not copyrighted, published or submitted elsewhere, except in abstract form. The corresponding author should ensure that all authors approve the manuscript before its submission.

Ethical conduct of research: The authors must describe and confirm safeguards to meet ethical standards when applicable. See Editorial Policy for details.

Conflict of interest: When authors submit a manuscript, they are responsible for recognizing and disclosing financial and/or other conflicts of interest that might bias their work and/or could inappropriately influence his/her judgment. If no specified acknowledgement is given, the Editors assume that no conflict of interest exists. Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Managing Editor.

Copyright: All authors retain copyright, unless – due to their local circumstances – their work is not copyrighted. The copyrights are governed by the Creative-Commons Attribution Only license (CC-BY) which is compliant with Plan-S. We may also publish a paper under CC-BY-NC-ND license on author's request. The corresponding author grants the journal the license to use of the article, by signing the License To Publish. Scanned copy of license should be sent to the journal, as soon as possible.

Authorship: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be named in an Acknowledgement section. The corresponding author should ensure that all appropriate co-authors (according to the above definition) and no inappropriate co-authors are included in the author list of the manuscript, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Peer Review process: Our standard policy requires each paper to be reviewed by at least two Referees and the peer-review process is single-blind. The Editors reserve the right to decline the submitted manuscript without review, if the studies reported are not sufficiently novel or important to merit publication in the journal. Manuscripts deemed unsuitable (insufficient originality or of limited interest to the target audience) are returned to the author(s) without review. The Editor seeks advice from experts in the appropriate field. Research articles and communications are refereed by a minimum of two reviewers, review papers by at least three. Authors are requested to suggest persons competent to review their manuscript. However, please note that this will be treated only as a suggestion, and the final selection of reviewers is exclusively the Editor's decision. The final decision of acceptance in made by Managing Editor or, in case of conflict, by the Editor-in-Chief.

Scientific Misconduct: This journal publishes only original manuscripts that are not also published or going to be published elsewhere. Multiple submissions/publications, or redundant publications (re-packaging in different words of data already published by the same authors) will be rejected. If they are detected only after publication, the journal reserves the right to publish a Retraction Note. In each particular case Editors will follow COPE’s Core Practices and implement the advices.

 

编辑邮箱【官网信息】

 

Editorial

Editor-in Chief

Maged Henary, Department of Chemistry, Georgia State University, Atlanta, USA (mhenary1@gsu.edu)

 

Managing Editor

Irmina Fortunato, irmina.fortunato@degruyter.com

 

Honorary Editor

Lucjan Strekowski, Georgia State University, Atlanta, USA (lucjan@gsu.edu)

 

Associate Editors

Alfons Baumstark, Georgia State University, Atlanta, USA (abaumstark@gsu.edu)

Naresh Gunaganti, Northeastern University, Boston, USA (naresh.gunaganti@gmail.com)

Yuliang Li, Chang’an University, China (yulianglee175@chd.edu.cn)

Ajay Mallia, Georgia Gwinnett College, Lawrenceville, USA (amallia@ggc.edu)

Kun Zhao, Chubu University, Kasugai, Japan (kunzhao13@gmail.com)

Wei Zhu, Northwestern University, Evanston, USA (wei.zhu@northwestern.edu)

 

Assistant Editor

Headar Abuirqeba, Catholic University of America, Washington DC, USA

 

Editorial Board

S. Abu-Orabi, Association of Arab Universities, Amman, Jordan (abuorabi@excite.com)

S. Achilefu, Washington University, St. Louis, USA (achilefus@mir.wustl.edu)

E.B. Arevalo-Garcia, Educational Research Institute, Warsaw, Poland (ebarevalog@gmail.com)

M. Brimble, University of Auckland, Auckland, New Zealand (m.brimble@auckland.ac.nz)

R.A. Bunce, Oklahoma State University, Stillwater, USA (rab@okstate.edu)

D. Das, Johns Hopkins School of Medicine, Baltimore, USA (ddas7@jhmi.edu)

M. Elliott, University of Cardiff, Cardiff, UK (elliottmc@cardiff.ac.uk)

D.C. Gautam, University of Rajasthan, Jaipur, India (drdcgautam@yahoo.co.in)

M.W. Germann, Georgia State University, Atlanta, USA (mwg@gsu.edu)

S. Gozem, Georgia State University, Atlanta, USA (sgozem@gsu.edu)

D. Hamelberg, Georgia State University, Atlanta, USA (dhamelberg@gsu.edu)

H. Kiyota, Okayama University, Okayama, Japan (kiyota@okayama-u.ac.jp)

K. Kiec-Kononowicz, Jagiellonian University, Kraków, Poland (mfkonono@cyf-kr.edu.pl)

M. Kumar, University of Rajasthan, Jaipur, India (mahendrakpathak@gmail.com)

H. Nishino, Kumamoto University, Kumamoto, Japan (nishino@sci.kumamoto-u.ac.jp)

T. Okano, Jikei University, Tokyo, Japan (okano@jikei.ac.jp)

S.S. Panda, Augusta University, Augusta, USA (sipanda@augusta.edu)

S.E. Patterson, UMN Center for Drug Design, Minneapolis, USA (patte219@umn.edu)

J. Reddy, Dr. Jagath Reddy's Heterocyclics, Hyderabad, India (jagathreddy@heterocyclics.com)

S. Routier, University of Orléans, Orléans, France (sylvain.routier@univ-orleans.fr)

A. Rykowski, University of Podlasie, Siedlce, Poland (rykowski@ap.siedlce.pl)

F. Saczewski, Medical University of Gdansk, Gdansk, Poland (saczew@amg.gda.pl)

S.W. Schneller, University of Auburn, Auburn, USA (schnest@auburn.edu)

B.C.G. Söderberg, University of West Virginia, Morgantown, USA (bjorn.soderberg@mail.wvu.edu)

V. Traven, Russian University of Chemical Technology, Moscow, Russia (traven@muctr.edu.ru)

B. Wang, Georgia State University, Atlanta, USA (wang@gsu.edu)

K. Weisz, Ernst Moritz Arndt University, Greifswald, Germany (weisz@uni-greifswald.de)

P.-F. Xu, Lanzhou University, Lanzhou, China (xupf@lzu.edu.cn)

P. Zajdel, Jagiellonian University Medical College, Kraków, Poland (pawel.zajdel@uj.edu.pl)

N. Zaware, Mount Sinai School of Medicine, New York, USA (nzaware@gmail.com)

A. Zawisza, University of Łódź, Łódź, Poland (aniazawisza@poczta.onet.pl)

Publisher

DE GRUYTER Poland

Bogumiła Zuga 32A Str.

01-811 Warsaw, Poland

T: +48 22 701 50 15

 

Editorial Contact

Dr. Irmina Fortunato

irmina.fortunato@degruyter.com


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭